An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder

被引:0
|
作者
Castry, Mathieu [1 ]
Tin, Yjuliana [2 ]
Feder, Noah M. [3 ]
Lewis, Nikki [4 ]
Chatterjee, Avik [4 ,5 ]
Rudorf, Maria [4 ]
Samet, Jeffrey H. [4 ,5 ]
Beers, Donna [4 ]
Medley, Bethany [6 ]
Gilbert, Louisa [6 ]
Linas, Benjamin P. [1 ,5 ]
Barocas, Joshua A. [2 ]
机构
[1] Boston Med Ctr, Sect Infect Dis, Boston, MA USA
[2] Univ Colorado, Div Gen Internal Med & Infect Dis, Sch Med, 12631 E 17th Ave,Mailstop B180, Aurora, CO 80045 USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] Boston Med Ctr, Sect Gen Internal Med, Boston, MA USA
[5] Boston Univ, Chobanian & Avedisian Sch Med, Boston, MA USA
[6] Columbia Univ, Sch Social Work, Social Intervent Grp, New York, NY USA
来源
JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT | 2024年 / 167卷
基金
美国国家卫生研究院;
关键词
Mobile health units; Opioid use disorder; Harm reduction; Medications for opioid use disorder; Economic evaluation; OVERDOSE; MASSACHUSETTS; BUPRENORPHINE; PROGRAM; IMPACT; STATES;
D O I
10.1016/j.josat.2024.209517
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background & objective: Mobile substance use treatment units are effective approaches to increase treatment access and reduce barriers to opioid use disorder (OUD) care. However, little is known about the economic costs of maintaining and operating these units. This study aimed to estimate the economic costs of starting and maintaining mobile units providing harm reduction, overdose education and naloxone distribution (OEND), and medication for opioid use disorder (MOUD). Methods: As part of the HEALing Communities Study, four communities in Massachusetts (Bourne/Sandwich, Brockton, Gloucester, Salem) implemented mobile units offering OEND and MOUD (buprenorphine and naltrexone only); each selected different services tailored to their community. All provided MOUD linkage via telehealth, but only one offered in-person MOUD prescribing on the unit. We retrospectively collected detailed resource utilization data from invoices to estimate the direct economic costs from August 2020 through June 2022. Cost components were categorized into start-up and operating costs. We calculated total economic cost over the study period and the average monthly operating cost. Results: Implementing a mobile unit offering OEND and MOUD required a one-time median start-up cost of $59,762 (range: $52,062-$113,671), with 80 % of those costs attributed to the vehicle purchase. The median monthly operating cost was $14,464. The largest cost category for all mobile units was personnel costs. The monthly ongoing costs varied by community settings and services: approximately $5000 for two urban communities offering OEND and MOUD linkage via telehealth (Gloucester, Salem), $28,000 for a rural community (Bourne/Sandwich), and $23,000 for an urban community also providing in-person MOUD prescribing on the unit (Brockton). Conclusion: The economic costs of mobile substance use treatment and harm reduction units are substantial but vary by community settings and services offered. Our results provide valuable community-level economic data to stakeholders and policymakers considering establishing and/or expanding mobile units with OEND and MOUD services. Further exploration of cost-effectiveness and efficiency should be considered across different settings.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Harm Reduction for Opioid Use Disorder
    Agrawal, Alok
    Bhad, Roshan
    Singh, Amit
    Rao, Ravindra
    INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (09) : S423 - S423
  • [2] Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter
    Tofighi, Babak
    El Shahawy, Omar
    Segoshi, Andrew
    Moreno, Katerine P.
    Badiei, Beita
    Sarker, Abeed
    Krawczyk, Noa
    JOURNAL OF ADDICTIVE DISEASES, 2020, 39 (01) : 37 - 45
  • [3] Harm Reduction Strategies for Opioid Use Disorder
    Knio, Laila
    Capurso, Noah
    CURRENT ADDICTION REPORTS, 2025, 12 (01)
  • [4] Layperson knowledge on naloxone and medications for opioid use disorder in an urban population: a cross sectional survey study
    Ramdin, Christine
    Zembrzuska, Malgorzata
    Zembrzuski, Krzysztof
    Nelson, Lewis
    JOURNAL OF ADDICTIVE DISEASES, 2025, 43 (02) : 153 - 161
  • [5] Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments
    Sasson, Comilla
    Dieujuste, Nathalie
    Klocko, Robert
    Basrai, Zahir
    Celedon, Manuel
    Hsiao, Jonie
    Himstreet, Julianne
    Hoffman, Jonathan
    Pfaff, Cassidy
    Malmstrom, Robert
    Smith, Jason
    Holstein, Ariel
    Johnson-Koenke, Rachel
    ACADEMIC EMERGENCY MEDICINE, 2023, 30 (04) : 289 - 298
  • [6] Opioid Use Disorder Stigma and Support for Harm Reduction in Rural Counties
    Whipple, Christopher R.
    Kaynak, Oevgue
    Kruis, Nathan E.
    Saylor, Erica
    Bonnevie, Erika
    Kensinger, Weston S.
    SUBSTANCE USE & MISUSE, 2023, 58 (14) : 1818 - 1828
  • [7] Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature
    Muzyk, Andrew
    Smothers, Zachary P. W.
    Collins, Kathryn
    MacEachern, Mark
    Wu, Li-Tzy
    SUBSTANCE ABUSE, 2019, 40 (04) : 476 - 483
  • [8] Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings Harm Reduction in Outpatient Addiction Treatment
    Taylor, Jessica L.
    Johnson, Samantha
    Cruz, Ricardo
    Gray, Jessica R.
    Schiff, Davida
    Bagley, Sarah M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (12) : 3810 - 3819
  • [9] Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis
    Muthulingam, Dharushana
    Hassett, Thomas C.
    Madden, Lynn M.
    Bromberg, Daniel J.
    Fraenkel, Liana
    Altice, Frederick L.
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 154
  • [10] Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use
    Shah, Khushbu P.
    Srivastava, Pronoma
    Modi, Viraj
    Lier, Audun J.
    HARM REDUCTION JOURNAL, 2024, 21 (01)